Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will hold a conference call on November 3, 2022, at 8:30 a.m. ET to discuss its financial results for the quarter ending September 30, 2022. This call aims to provide a corporate update and invite stakeholders to participate via a registration link. Interested parties can access the live and archived webcast through the Investor Relations section of the company's website. Intra-Cellular Therapies specializes in developing treatments for central nervous system disorders, leveraging innovative insights from cellular research.
- None.
- None.
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, November 3, 2022, to provide a corporate update and discuss details of the Company's financial results for the quarter ended September 30, 2022.
To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.
The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006
FAQ
When will Intra-Cellular Therapies discuss its financial results for Q3 2022?
How can I attend the Intra-Cellular Therapies conference call?
Where can I find the archived webcast for Intra-Cellular Therapies' conference call?
